Form D · Biotechnology
Mid-Atlantic BioTherapeutics, Inc.
Doylestown, PA · CIK 0001755678
Offering snapshot reported Sep 30, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 11, 2018 | Initial | $875,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $500K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-525424
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NONE | None | Mallory Capital Group, LLC · CRD 108486 |
Source: Form D, filed Sep 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julian Chick | Director |
| Jean Pierre Gagnon | Director |
| Michael Goldblatt | Director |
| David Horn | Director, Executive |
| David Jobes | Director, Executive |
| Andrew Katz | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3805 Old Easton Road
Doylestown, PA, 18902
Doylestown, PA, 18902